Protease Activity in Vascular Disease.
Protease Activity in Vascular Disease.
复制标题
DOI:
10.1161/atvbaha.119.312413
复制
发表时间:
2019-09
期刊:
影响因子:
--
通讯作者:
Megan Slack;S. Gordon
中科院分区:
文献类型:
--
作者:
Megan Slack;S. Gordon
Protease activity has been implicated in the pathogenesis of vascular diseases, including atherosclerosis, thrombosis, and aneurysm. A wide variety of proteases representing different proteolytic families and their corresponding inhibitors are involved. These proteases contribute to vascular disease through a series of overlapping pathways that affect overall inflammatory status and structural integrity of the vessel wall. By activating PARs (protease-activated receptors), these enzymes propagate inflammatory signaling, cytokine production, and inflammatory cell recruitment. Additionally, proteases can degrade components of the extracellular matrix (ECM), elastic lamina, and fibrous cap in atheroma. The prevailing paradigm is that excessive proteolytic activity is a significant contributor to the initiation and progression of vascular disease. Recent approaches to treatment of vascular pathologies have attempted to modulate protease activity in an effort to reduce inflammation and preserve structural integrity of the vessel wall. This Highlight article will review foundational evidence for the role of extracellular protease activity in vascular pathology (Figure) with a focus on the most recent discoveries and approaches to treatment. Advances related to atherosclerosis and aneurysm will be primarily emphasized as the role of protease activity in thrombosis has been recently reviewed.